Cargando…

The association between different predictive biomarkers and mortality of COVID-19

BACKGROUND: Immunocompromised individuals are expected to be more prone to severe diseases and, subsequently, death. Genetic disorders and polymorphisms in genes involved in the immune system, such as human leukocyte antigen (HLA), inflammatory cytokines, and killer-cell immunoglobulin-like receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Narges, Jahangiri, Mina, Shirbandi, Kimia, Ebrahimi, Mina, Rahim, Fakher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152825/
https://www.ncbi.nlm.nih.gov/pubmed/35669157
http://dx.doi.org/10.1186/s42269-022-00844-7
_version_ 1784717719037280256
author Ansari, Narges
Jahangiri, Mina
Shirbandi, Kimia
Ebrahimi, Mina
Rahim, Fakher
author_facet Ansari, Narges
Jahangiri, Mina
Shirbandi, Kimia
Ebrahimi, Mina
Rahim, Fakher
author_sort Ansari, Narges
collection PubMed
description BACKGROUND: Immunocompromised individuals are expected to be more prone to severe diseases and, subsequently, death. Genetic disorders and polymorphisms in genes involved in the immune system, such as human leukocyte antigen (HLA), inflammatory cytokines, and killer-cell immunoglobulin-like receptors, can be involved in the immune system's response to various pathogens. In the current survey, the data were received from the world health organization, collected around the world. RESULTS: Spearman's coefficient correlation test for evaluating the relationship between the Daily Death Rates (DDR) and immunological variables showed a statistically significant correlation between the DDR and all immunological variables except TNFa857T, TNFa863A IL2330G, and IL2166T (P < 0.001). Also, there was a statistically significant correlation between the DDR and some HLA markers. CONCLUSION: This meta-analysis study shows that predictive biomarkers and mortality of COVID-19 are associated with HLA markers. However, these results should be confirmed in a more structured agreement. It is worth noting that the design of new studies should consider potential diseases with poor prognoses because they are related to these immune genetic markers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42269-022-00844-7.
format Online
Article
Text
id pubmed-9152825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91528252022-06-02 The association between different predictive biomarkers and mortality of COVID-19 Ansari, Narges Jahangiri, Mina Shirbandi, Kimia Ebrahimi, Mina Rahim, Fakher Bull Natl Res Cent Research BACKGROUND: Immunocompromised individuals are expected to be more prone to severe diseases and, subsequently, death. Genetic disorders and polymorphisms in genes involved in the immune system, such as human leukocyte antigen (HLA), inflammatory cytokines, and killer-cell immunoglobulin-like receptors, can be involved in the immune system's response to various pathogens. In the current survey, the data were received from the world health organization, collected around the world. RESULTS: Spearman's coefficient correlation test for evaluating the relationship between the Daily Death Rates (DDR) and immunological variables showed a statistically significant correlation between the DDR and all immunological variables except TNFa857T, TNFa863A IL2330G, and IL2166T (P < 0.001). Also, there was a statistically significant correlation between the DDR and some HLA markers. CONCLUSION: This meta-analysis study shows that predictive biomarkers and mortality of COVID-19 are associated with HLA markers. However, these results should be confirmed in a more structured agreement. It is worth noting that the design of new studies should consider potential diseases with poor prognoses because they are related to these immune genetic markers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42269-022-00844-7. Springer Berlin Heidelberg 2022-05-31 2022 /pmc/articles/PMC9152825/ /pubmed/35669157 http://dx.doi.org/10.1186/s42269-022-00844-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Ansari, Narges
Jahangiri, Mina
Shirbandi, Kimia
Ebrahimi, Mina
Rahim, Fakher
The association between different predictive biomarkers and mortality of COVID-19
title The association between different predictive biomarkers and mortality of COVID-19
title_full The association between different predictive biomarkers and mortality of COVID-19
title_fullStr The association between different predictive biomarkers and mortality of COVID-19
title_full_unstemmed The association between different predictive biomarkers and mortality of COVID-19
title_short The association between different predictive biomarkers and mortality of COVID-19
title_sort association between different predictive biomarkers and mortality of covid-19
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152825/
https://www.ncbi.nlm.nih.gov/pubmed/35669157
http://dx.doi.org/10.1186/s42269-022-00844-7
work_keys_str_mv AT ansarinarges theassociationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT jahangirimina theassociationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT shirbandikimia theassociationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT ebrahimimina theassociationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT rahimfakher theassociationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT ansarinarges associationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT jahangirimina associationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT shirbandikimia associationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT ebrahimimina associationbetweendifferentpredictivebiomarkersandmortalityofcovid19
AT rahimfakher associationbetweendifferentpredictivebiomarkersandmortalityofcovid19